Your browser doesn't support javascript.
loading
Prophylactic pulmonary vein isolation during cavotricuspid isthmus ablation for atrial flutter: A meta-analysis.
Koerber, Scott M; Turagam, Mohit K; Gautam, Sandeep; Winterfield, Jeffrey; Wharton, J Marcus; Lakkireddy, Dhanunjaya; Gold, Michael R.
Affiliation
  • Koerber SM; Division of Cardiology, Medical University of South Carolina, Charleston, South Carolina.
  • Turagam MK; Division of Cardiology, Mount Sinai School of Medicine, New York City, New York.
  • Gautam S; Division of Cardiology, University of Missouri-Columbia, Columbia, Missouri.
  • Winterfield J; Division of Cardiology, Medical University of South Carolina, Charleston, South Carolina.
  • Wharton JM; Division of Cardiology, Medical University of South Carolina, Charleston, South Carolina.
  • Lakkireddy D; Division of Cardiology, Kansas City Heart Rhythm Institute, Kansas City, Kanas.
  • Gold MR; Division of Cardiology, Medical University of South Carolina, Charleston, South Carolina.
Pacing Clin Electrophysiol ; 42(5): 493-498, 2019 05.
Article in En | MEDLINE | ID: mdl-30779174
ABSTRACT

BACKGROUND:

Atrial arrhythmias (AA), including atrial fibrillation (AF), have been reported in patients after cavotricuspid isthmus (CTI) ablation for typical atrial flutter (AFL). Several studies have examined the effect of performing concomitant pulmonary vein isolation (PVI) with CTI on recurrent AA. These studies were analyzed to determine the overall effect of this approach on recurrent AA.

METHODS:

PubMed and Google Scholar were searched for randomized trials comparing the incidence of AA after CTI versus CTI + PVI until June 2018. Only patients without prior history of AF were included in the recurrent AA analysis. All patients were included in the analyses of other clinical outcomes.

RESULTS:

Four randomized control trials were included in the meta-analysis. In the recurrent AA analysis, a total of 314 patients were randomized in the studies (n = 158 CTI, n = 156 CTI + PVI). Freedom from AA at 1 year was significantly higher in the CTI + PVI group versus CTI alone (odds ratio [OR] 0.25 [0.14, 0.44] 95% confidence interval [CI], P < 0.00001). A total of 550 patients (n = 336 CTI, n = 214 CTI + PVI) were included in analyses for procedure time, fluoroscopy time, and complications rates. Procedure time and fluoroscopy time were significantly longer in the CTI + PVI group (mean difference [MD] 103.31 min [94.40, 112.23] 95% CI, P < 0.00001) and (MD 16.47 min [14.89, 18.05] 95% CI, P < 0.00001), respectively. Total complications were statistically similar between groups.

CONCLUSION:

This meta-analysis shows addition of a prophylactic PVI during CTI ablation significantly reduces recurrent AA at 1 year without significantly increasing major complications.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Postoperative Complications / Pulmonary Veins / Atrial Fibrillation / Atrial Flutter / Tricuspid Valve Type of study: Clinical_trials / Etiology_studies / Systematic_reviews Limits: Humans Language: En Year: 2019 Type: Article

Full text: 1 Database: MEDLINE Main subject: Postoperative Complications / Pulmonary Veins / Atrial Fibrillation / Atrial Flutter / Tricuspid Valve Type of study: Clinical_trials / Etiology_studies / Systematic_reviews Limits: Humans Language: En Year: 2019 Type: Article